Vanessa Small is the dynamic CEO of Alcheme Bio, a cutting-edge biotechnology firm revolutionizing the field of personalized medicine. With over 15 years of experience in the biotech industry, Vanessa has spearheaded initiatives that integrate AI and sensory data to develop tailored enzyme solutions. Under her leadership, Alcheme Bio has expanded its global footprint, establishing partnerships with leading food manufacturers. Vanessa is passionate about fostering innovation and is committed to driving advancements that improve health outcomes worldwide.More...